Completing data — refresh the page later to see the latest
208993-54-8COc1cccc2c1[C@@H]1CN(CCCCn3c(=O)[nH]c4c(sc5ncc(-c6ccccc6)nc54)c3=O)C[C@@H]1CO2WDTAYDBPNYFWDR-WOJBJXKFSA-NFiduxosin is a small molecule drug. Fiduxosin has a monoisotopic molecular weight of 555.19 Da.
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Drug Induced Liver Injury Rank (DILIrank 2.0)
Fiduxosin
vMost-DILI-concern
8
Discontinued
DOI:10.1016/j.drudis.2016.02.015
UsesFiduxosin is a novel α1a-adrenoceptor antagonist that may be used for the treatment of benign prostatic hyperplasia. (Abbot Labs)
208993-54-8DTXSID401017163CHEMBL1256183